tiprankstipranks
Advertisement
Advertisement

TAK Stock Latest News

Takeda Deepens Its Rare Disease Data Moat With New AATD Liver Study
Company AnnouncementsTakeda Deepens Its Rare Disease Data Moat With New AATD Liver Study
2d ago
TAK
Takeda’s Elritercept Trial Targets Anemia in Myelofibrosis, Raising Long-Term Upside for TAK
PremiumCompany Announcements
Takeda’s Elritercept Trial Targets Anemia in Myelofibrosis, Raising Long-Term Upside for TAK
2d ago
TAK
Takeda dengue vaccine receives marketing authorization from India DCGI
PremiumThe Fly
Takeda dengue vaccine receives marketing authorization from India DCGI
5d ago
TAK
Takeda’s TAK-226 Anemia Trial Offers New Optionality in Hematology
PremiumCompany Announcements
Takeda’s TAK-226 Anemia Trial Offers New Optionality in Hematology
10d ago
TAK
Takeda Extends TAK-360 Sleep Trial, Signaling Long-Term Ambitions in Narcolepsy
PremiumCompany Announcements
Takeda Extends TAK-360 Sleep Trial, Signaling Long-Term Ambitions in Narcolepsy
11d ago
TAK
Takeda’s Takhzyro Real‑World Pediatric Study Wraps Up, Setting the Stage for Next Moves
PremiumCompany AnnouncementsTakeda’s Takhzyro Real‑World Pediatric Study Wraps Up, Setting the Stage for Next Moves
12d ago
TAK
Takeda, the Indoensian Government announce collaboration
Premium
The Fly
Takeda, the Indoensian Government announce collaboration
13d ago
TAK
Takeda Files July 2026 Corporate Governance Report Highlighting Full Code Compliance
Premium
Company Announcements
Takeda Files July 2026 Corporate Governance Report Highlighting Full Code Compliance
17d ago
6K
TAK
Takeda Updates Articles of Incorporation in June 2026 SEC Filing
PremiumCompany Announcements
Takeda Updates Articles of Incorporation in June 2026 SEC Filing
27d ago
6K
TAK
Takeda Shareholders Approve Dividend and Board Slate at 150th Annual Meeting
PremiumCompany Announcements
Takeda Shareholders Approve Dividend and Board Slate at 150th Annual Meeting
30d ago
6K
TAK
Takeda CEO Christophe Weber retires, Julie Kim succeeds
PremiumThe Fly
Takeda CEO Christophe Weber retires, Julie Kim succeeds
1M ago
TAK
Takeda Canada reports ‘positive’ results from Phase 3 study of zasocitinib
PremiumThe Fly
Takeda Canada reports ‘positive’ results from Phase 3 study of zasocitinib
1M ago
TAK
Takeda’s New Polish Study Tracks Real-World Impact of Fruquintinib in Advanced Colorectal Cancer
PremiumCompany AnnouncementsTakeda’s New Polish Study Tracks Real-World Impact of Fruquintinib in Advanced Colorectal Cancer
1M ago
TAK
Takeda’s High-Stakes Overhaul: CEO Transition and Major Restructuring Raise Execution and Profitability Risks
Premium
Company Announcements
Takeda’s High-Stakes Overhaul: CEO Transition and Major Restructuring Raise Execution and Profitability Risks
1M ago
TAK
Takeda presents additional results from oveporexton studies at SLEEP 2026
Premium
The Fly
Takeda presents additional results from oveporexton studies at SLEEP 2026
1M ago
TAK
Takeda announces results for Phase 3 study of TAK-279
PremiumThe Fly
Takeda announces results for Phase 3 study of TAK-279
1M ago
TAK
FDA accepts Takeda’s application for intravenous Entyvio
PremiumThe Fly
FDA accepts Takeda’s application for intravenous Entyvio
2M ago
TAK
Takeda’s TAK-360 Narcolepsy Trial Moves Forward, Expanding Its Specialty CNS Pipeline
PremiumCompany Announcements
Takeda’s TAK-360 Narcolepsy Trial Moves Forward, Expanding Its Specialty CNS Pipeline
2M ago
TAK
Takeda’s New Mezagitamab Trial Targets High-Risk Kidney Rejection, Bolstering Long-Term Pipeline Story
PremiumCompany Announcements
Takeda’s New Mezagitamab Trial Targets High-Risk Kidney Rejection, Bolstering Long-Term Pipeline Story
2M ago
TAK
Takeda’s Real-World Maribavir Study in Argentina: What Investors Should Watch
PremiumCompany AnnouncementsTakeda’s Real-World Maribavir Study in Argentina: What Investors Should Watch
2M ago
TAK
Innovent Biologics announces results from PoC study of IBI363
Premium
The Fly
Innovent Biologics announces results from PoC study of IBI363
2M ago
TAK
Takeda to Revise FY2025 IFRS Earnings Report After U.S. AMITIZA Antitrust Verdict
Premium
Company Announcements
Takeda to Revise FY2025 IFRS Earnings Report After U.S. AMITIZA Antitrust Verdict
2M ago
6K
TAK

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >